step semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial Novo Nordisk announced headline results

While the medication does not carry an FDA label warning specifically about alcohol, the interaction between semaglutide and alcohol use is more nuanced than a simple yes or no answer

Research shows that some weight loss from the medication involves muscle loss rather than fat loss

BMI Between 30 and 35 Requires associated conditions such as uncontrolled hypertension or advanced stage chronic kidney disease

Most gastrointestinal side effects diminish significantly after 48 weeks of continuous treatment at a stable dose, though individual experiences vary considerably

Were breaking down peanut butter nutrition facts and answering the most common questions about peanut butter and low carb diets

Understanding your GLP1R, GIPR, MC4R, and FTO variants before starting treatment helps your clinician select the right medication and dose from day one, reducing the likelihood of plateau or weight regain later